Adjuvant properties of aluminum and calcium compounds.

[1]  M. Granström,et al.  Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. , 1995, Vaccine.

[2]  M. Granström,et al.  Immunogloblin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines , 1994, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[3]  R. Gupta,et al.  Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. , 1994, Biologicals : journal of the International Association of Biological Standardization.

[4]  M. Granström,et al.  The role of aluminium for adverse reactions and immunogenicity of diphtheria‐tetanus booster vaccine , 1994, Acta paediatrica.

[5]  G. Ada.  Strategies in vaccine design. , 1994 .

[6]  M. Granström,et al.  Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. , 1994, Vaccine.

[7]  J. Chermann,et al.  Humoral response in rabbits immunized with calcium phosphate adjuvanted HIV-1 gp160 antigen. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  F. Regnier,et al.  Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants. , 1994, Vaccine.

[9]  A. Shafferman,et al.  Novel Adjuvant Strategies for Experimental Malaria and AIDS Vaccines , 1993, Annals of the New York Academy of Sciences.

[10]  F. Audibert,et al.  Adjuvants: current status, clinical perspectives and future prospects. , 1993, Trends in pharmacological sciences.

[11]  Rajesh K. Gupta,et al.  Adjuvants--a balance between toxicity and adjuvanticity. , 1993, Vaccine.

[12]  C. Alving,et al.  Summary: Adjuvants/Clinical Trials Working Group. , 1992, AIDS research and human retroviruses.

[13]  R. Gupta,et al.  Comparative stabilities of glutaraldehyde & heat inactivated pertussis vaccine components of adsorbed DPT vaccine with different preservatives. , 1992, The Indian journal of medical research.

[14]  J. Peetermans.  Production, quality control and characterization of an inactivated hepatitis A vaccine. , 1992, Vaccine.

[15]  R. Kennedy,et al.  Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160. , 1992, Viral immunology.

[16]  C. Kensil,et al.  Development of a genetically engineered vaccine against feline leukemia virus infection. , 1991, Journal of the American Veterinary Medical Association.

[17]  R. Gupta,et al.  Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine. , 1991, Vaccine.

[18]  G. Siber,et al.  Safety and immunogenicity of hydrogen peroxide-inactivated pertussis toxoid in 18-month-old children. , 1991, Vaccine.

[19]  L. Nencioni,et al.  Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa. , 1991, Vaccine.

[20]  Eldridge,et al.  Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies , 1991, Infection and immunity.

[21]  P. Cooper,et al.  The adjuvanticity of Algammulin, a new vaccine adjuvant. , 1991, Vaccine.

[22]  M. Huet,et al.  Antibody response of pregnant women to two different absorbed tetanus toxoids. , 1991, Vaccine.

[23]  R. Gupta,et al.  Immunogenicity of glutaraldehyde inactivated pertussis vaccine. , 1990, Vaccine.

[24]  R. Schneerson,et al.  Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children. , 1990, The Journal of pediatrics.

[25]  F E André,et al.  Inactivated candidate vaccines for hepatitis A. , 1990, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[26]  J L Grun,et al.  Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. , 1989, Cellular immunology.

[27]  Woodard Lf.  Adjuvant activity of water-insoluble surfactants. , 1989 .

[28]  R. Bomford.  Aluminium Salts: Perspectives in their use as Adjuvants , 1989 .

[29]  D. Stewart-Tull.  Recommendations for the Assessment of Adjuvants (Immunopotentiators) , 1989 .

[30]  M. Granström,et al.  Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine. , 1989, International archives of allergy and applied immunology.

[31]  G. Poste,et al.  Immunological Adjuvants and Vaccines , 1989, NATO ASI Series.

[32]  R. Schneerson,et al.  Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. , 1988, The Journal of pediatrics.

[33]  Adhocgroupforthestudyofpert.  PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN?PROTECIVE EFFICACY AND ADVERSE EVENTS , 1988 .

[34]  C. Koch,et al.  On the effect of Al(OH)3 as an immunological adjuvant , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[35]  R. Gupta,et al.  The effect of aluminium phosphate adjuvant on the potency of pertussis vaccine. , 1987, Journal of biological standardization.

[36]  D. Granoff,et al.  IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEIN , 1986, The Lancet.

[37]  R. Gupta,et al.  Antibody response of guinea pigs to fluid and adsorbed tetanus toxoids. , 1986, Indian journal of pathology & microbiology.

[38]  H. Braley‐Mullen,et al.  Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. , 1986, Cellular immunology.

[39]  L. Chedid,et al.  Current status of immunological adjuvants. , 1986, Annual review of immunology.

[40]  B. Yvonnet,et al.  Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen , 1986, Infection and immunity.

[41]  Relyveld Eh.  Preparation and use of calcium phosphate adsorbed vaccines. , 1986 .

[42]  M. Nielsen,et al.  Persistent Subcutaneous Nodules in Children Hyposensitized with Aluminium‐Containing Allergen Extracts , 1985, Allergy.

[43]  G. Zlabinger,et al.  Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. , 1985, Clinical and experimental immunology.

[44]  E. Relyveld,et al.  Calcium phosphate adjuvanted allergens. , 1985, Annals of allergy.

[45]  L. Lasky,et al.  Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. , 1985, Science.

[46]  M. Cogné,et al.  Total and IgE antibody levels following booster immunization with aluminum absorbed and nonabsorbed tetanus toxoid in humans. , 1985, Annals of allergy.

[47]  J. May,et al.  The aluminum content of biological products containing aluminum adjuvants: determination by atomic absorption spectrometry. , 1984, Journal of biological standardization.

[48]  A. Hinnen,et al.  Hepatitis B virus antigens made in microbial cells immunise against viral infection. , 1984, The EMBO journal.

[49]  Y. Sato,et al.  DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPAN , 1984, The Lancet.

[50]  R. Bomford.  Relative adjuvant efficacy of Al(OH)3 and saponin is related to the immunogenicity of the antigen. , 1984, International archives of allergy and applied immunology.

[51]  F. N. Marie,et al.  Calcium-phosphate-adjuvanted allergens: total and specific IgE levels before and after immunotherapy with house dust and Dermatophagoides pteronyssinus extracts. , 1983, Annales d'immunologie.

[52]  H. Ikegami,et al.  Elevation of levels of IgE antibody to tetanus toxin in individuals vaccinated with diphtheria-pertussis-tetanus vaccine. , 1982, The Journal of infectious diseases.

[53]  D. Tyrrell.  New Developments with Human and Veterinary Vaccines , 1981 .

[54]  J. Cameron.  The potency of whooping cough (pertussis) vaccines in Canada. , 1980, Journal of biological standardization.

[55]  O. Clemmensen,et al.  Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen , 1980, Contact dermatitis.

[56]  R. Bomford.  The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin , 1980, Clinical and experimental immunology.

[57]  R. Bomford.  The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bord , 1980, Clinical and experimental immunology.

[58]  Relyveld Eh.  Current developments in production and testing of tetanus and diphtheria vaccines. , 1980 .

[59]  J L Turk,et al.  Complement activation by aluminium and zirconium compounds. , 1979, Immunology.

[60]  L. Collier,et al.  REACTIONS AND ANTIBODY RESPONSES TO REINFORCING DOSES OF ADSORBED AND PLAIN TETANUS VACCINES , 1979, The Lancet.

[61]  N. Preston.  Some unsolved problems with vaccines. , 1979, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[62]  T. Vassilev,et al.  Aluminium Phosphate but Not Calcium Phosphate Stimulates the Specific IgE Response in Guinea Pigs to Tetanus Toxoid , 1978, Allergy.

[63]  W. Dewitt,et al.  A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75. , 1978, Bulletin of the World Health Organization.

[64]  E. Kuwert,et al.  Antigenicity of low concentrated HDCS vaccine with and without adjuvant as compared to the standard fluid formulation. , 1978, Developments in biological standardization.

[65]  R. Walls.  Eosinophil Response to Alum Adjuvants: Involvement of T Cells in Non-Antigen-Dependent Mechanisms 1 , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[66]  P. Fireman,et al.  IgE synthesis in man. I. Development of specific IgE antibodies after immunization with tetanus-diphtheria (Td) toxoids. , 1977, Journal of immunology.

[67]  N. Preston.  PROTECTION BY PERTUSSIS VACCINE Little Cause for Concern , 1976, The Lancet.

[68]  V. B. Joshi,et al.  Field trial on frozen and thawed tetanus toxoid. , 1976, The Indian journal of medical research.

[69]  J. Cameron.  Problems associated with the control testing of pertussis vaccine. , 1976, Advances in applied microbiology.

[70]  P. Novotný,et al.  The use of Bordetella pertussis preserved in liquid nitrogen as a challenge suspension in the Kendrick mouse protection test. , 1975, Journal of Biological Standardization.

[71]  N. Preston,et al.  Pertussis agglutinins in vaccinated children: better response with adjuvant , 1974, Journal of Hygiene.

[72]  Relyveld Eh,et al.  ETUDE D'UNE NOUVELLE ASSOCIATION VACCINALE QUINTUPLE , 1973 .

[73]  L. Levine.  A predictive equation for the primary immune response of mice to adsorbed tetanus toxoid as a function of dose of antigen and dose of adjuvant. , 1972, Journal of Immunology.

[74]  R. Newman,et al.  Aluminium hydroxide granuloma. , 1971, British medical journal.

[75]  P. G. Munder,et al.  The influence of various adjuvants on the metabolism of phospholipids in macrophages. , 1969, International archives of allergy and applied immunology.

[76]  F. Askin,et al.  Communications Lack of Adjuvant Effect of AIPO4 on Purified Influenza Virus Hemagglutinins in Man , 1968 .

[77]  Aprile Ma,et al.  Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. , 1966 .

[78]  L. Levine,et al.  Active-passive tetanus immunization. Choice of toxoid, dose of tetanus immune globulin and timing of injections. , 1966, New England Journal of Medicine.

[79]  A. J. Fulthorpe.  The influence of mineral carriers on the simultaneous active and passive immunization of guinea-pigs against tetanus , 1965, Journal of Hygiene.

[80]  B. Cvjetanović,et al.  THE PRESENT STATUS OF FIELD AND LABORATORY STUDIES OF TYPHOID AND PARATYPHOID VACCINES WITH SPECIAL REFERENCE TO STUDIES SPONSORED BY WORLD HEALTH ORGANIZATION. , 1965, Bulletin of the World Health Organization.

[81]  M. Raynaud,et al.  [STUDY OF THE ANTIDIPHTHERIA VACCINATION OF ALLERGIC SUBJECTS WITH A PURE ANATOXIN ABSORBED ON CALCIUM PHOSPHATE]. , 1964, Bulletin of the World Health Organization.

[82]  A. H. Coons,et al.  STUDIES ON ANTIBODY PRODUCTION VIII. THE INHIBITORY EFFECT OF CHLORAMPHENICOL ON THE SYNTHESIS OF ANTIBODY IN TISSUE CULTURE , 1963 .

[83]  G. Guarini,et al.  Steatorrhoea in Addison's disease. , 1963, Lancet.

[84]  P. Benson,et al.  Effect of aluminium phosphate on antibody response to killed poliomyelitis vaccne. , 1962, Lancet.

[85]  P. Benson,et al.  Response of infants to pertussis vaccine at one week and to poliomyelitis, diphtheria, and tetanus vaccine at six months. , 1962, Lancet.

[86]  S. Rubbo,et al.  Immunization against tetanus , 1961, Journal of Hygiene.

[87]  L. Levine,et al.  Adult immunization. Preparation and evaluation of combined fluid tetanus and diphtheria toxoids for adult use. , 1961, American journal of hygiene.

[88]  L. Levine,et al.  Factors affecting the efficiency of the aluminum adjuvant in diphtheria and tetanus toxoids. , 1955, Journal of Immunology.

[89]  R. White,et al.  Studies on antibody production. III. The alum granuloma. , 1955 .

[90]  L. Holt.  AN ATTEMPT TO DERIVE A MATHEMATICAL CHARACTER- IZATION OF THE ANTIGENICITY OF DIPHTHERIA PROPHYLACTIC* , 1955 .

[91]  W. Keller,et al.  Grundsätzliches zur aktiven Schutzimpfung gegen Poliomyelitis , 1955 .

[92]  J. Ipsen.  Immunization of adults against diphtheria and tetanus. , 1954, The New England journal of medicine.

[93]  M. Pittman.  Variability of the potency of pertussis vaccine in relation to the number of bacteria. , 1954, The Journal of pediatrics.

[94]  L. Holt.  Developments in Diphtheria Prophylaxis. , 1950 .

[95]  S. Seal,et al.  Studies on the Purification of Alum-Precipitated Diphtheria Toxoid , 1941 .

[96]  V. K. Volk,et al.  Diphtheria Immunization With Fluid Toxoid and Alum Precipitated Toxoid -Preliminary Report. , 1939, American Journal of Public Health and the Nations Health.

[97]  H. Gold.  Studies on tetanus toxoid , 1937 .

[98]  J. Moss,et al.  Studies on Tetanus Toxoid I. The Antitoxic Titer of Human Subjects Following Immunization with Tetanus Toxoid and Tetanus Alum Precipitated Toxoid , 1936 .

[99]  W. T. Harrison.  Some Observations on the Use of Alum Precipitated Diphtheria Toxoid. , 1935, American journal of public health and the nation's health.

[100]  John L. White,et al.  DIPHTHERIA TOXOID: COMPARATIVE IMMUNIZING VALUE WITH AND WITH-OUT ALUM, AS INDICATED BY THE SCHICK TEST , 1934 .

[101]  A. Glenny,et al.  Rate of Disappearance of Diphtheria Toxoid injected into Rabbits and Guinea-Pigs: Toxoid precipitated with Alum. , 1931 .